Literature DB >> 21479388

HPV infection in Brazilian oral squamous cell carcinomapatients and its correlation with clinicopathological outcomes.

Lucinei Roberto Oliveira1, Alfredo Ribeiro-Silva, Leandra Naira Zambelli Ramalho, Aguinaldo Luiz Simões, Sergio Zucoloto.   

Abstract

This study aims to investigate human papilloma virus (HPV) frequency in Brazilian patients with oral squamous cell carcinoma (OSCC) in order to establish a clinicopathological profile. It will also examine the correlation between patient survival and HPV expression in primary tumors (PTs), and their matched samples (MSs) of recidives, lymph nodal metastasis (LNM) or necropsies. Eighty-seven PTs and their corresponding 87 MSs were tested for HPV infection by polymerase chain reaction (PCR) using general and type-specific HPV primers. The following data were obtained from patient medical files: primary site, age, gender, tobacco consumption, histological differentiation, recurrences, metastasis, disease-free survival (DFS) and overall survival (OS). Of the 87 patients investigated, 17 (19.5%) were found to have HPV DNA in their tumors. An investigation of all the paraffin-embedded specimens revealed the presence of HPV DNA in 18 of the 174 samples (10.4%), 10 (11.5%) from PTs and 8 (9.2%) from MSs. No virus was detected in the corresponding PT of 7 (8.1%) MSs, and only one patient demonstrated HPV DNA positivity in both samples. The HPV genotypes 16 and 18 were detected in 4 (22.2%) and 3 (16.7%) of the positive samples, respectively. Infection with both genotypes was found in 6 (33.3%) investigated samples, and the HPV genotype was unidentified in 5 (27.8%) samples. The tongue was the most prevalent infected anatomical site. We did not find any significant association between HPV infection and gender, age, histological differentiation, DFS or OS. A significant number of HPV samples were positive among non-smoking patients. Although a possible influence of the virus on tumoral induction cannot be ruled out, the low frequency of OSCC cases that contain HPV does not suggest that this virus has the same etiological influence on patients as tobacco consumption does.

Entities:  

Year:  2008        PMID: 21479388

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.

Authors:  Katinka Kansy; Oliver Thiele; Kolja Freier
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

2.  Human papillomavirus prevalence in oral and oropharyngeal squamous cell carcinoma in South America: A systematic review and meta-analysis.

Authors:  Antônio Carlos Oliveira; Israel Carlos Cavalcanti de Lima; Vitor Marcelo Frez Marques; Wudson Henrique Alves de Araújo; Chrystiano de Campos Ferreira
Journal:  Oncol Rev       Date:  2022-03-24

3.  Middle ear squamous papilloma: A report of four cases analyzed by HPV and EBV in situ hybridization.

Authors:  Han Zhou; Zhibin Chen; Weiming Zhang; Guangqian Xing
Journal:  Oncol Lett       Date:  2013-11-11       Impact factor: 2.967

Review 4.  Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.

Authors:  Frans J Mulder; Damiana D C G Pierssens; Laura W J Baijens; Bernd Kremer; Ernst-Jan M Speel
Journal:  Head Neck       Date:  2020-10-23       Impact factor: 3.147

5.  Human papillomavirus in oral cavity and oropharynx carcinomas in the central region of Brazil.

Authors:  Guilherme Petito; Megmar Aparecida Dos Santos Carneiro; Sílvia Helena de Rabello Santos; Antonio Marcio Teodoro Cordeiro Silva; Rita de Cassia Alencar; Antonio Paulo Gontijo; Vera Aparecida Saddi
Journal:  Braz J Otorhinolaryngol       Date:  2016-04-09

Review 6.  Prevalence of oral and oropharyngeal human papillomavirus infection in Brazilian population studies: a systematic review.

Authors:  Leandro Luongo de Matos; Giuliana Angelucci Miranda; Claudio Roberto Cernea
Journal:  Braz J Otorhinolaryngol       Date:  2015-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.